It has been reported that the Notch signaling pathway is blocked by DAPT treatment in some inflammatory disease models, such as asthma, autoimmune encephalomyelitis, and psoriasis, which is accompanied by decreased Th17 cell percentage and IL-17A level as well as significant improvement in disease severity [8, 23, 30, 31]. The gene discussed is IL17A; the disease is asthma.